ReNu Lawsuit & News Blog
ReNu Lawsuits and Class Actions | ReNu Eye Infection Blog Home | ReNu Archives | ReNu Articles | ReNu Eye Infections Category Index |
Do I have an AMO MoisturePlus Lawsuit?
|
Do I have a ReNu Lawsuit?
ReNu Lawsuits and Class Actions : ReNu Eye Infection Blog Home : FDA : Article

Advanced Medical Optics Complete MoisturePlus Contact Lens Solution: Recall Due to Reports of A Rare, But Serious, Eye Infection Caused by A Parasite

Subject: FDA - MedWatch - Advanced Medical Optics Complete MoisturePlus Contact Lens Solution: Recall Due to Reports of A Rare, But Serious, Eye Infection Caused by A Parasite

MedWatch - The FDA Safety Information and Adverse Event Reporting Program

Advanced Medical Optics and FDA informed healthcare professionals and consumers who wear soft contact lenses of a recall of Complete MoisturePlus Multi-Purpose Solution manufactured by Advanced Medical Optics. The recall is based on reports of a rare, but serious, eye infection, Acanthamoeba keratitis, caused by a parasite. The link between the solution and the infection was identified as a result of an investigation by the Centers for Disease Control and Prevention (CDC).

Acanthamoeba keratitis may lead to vision loss with some patients requiring a corneal transplant. The infection primarily affects otherwise healthy people who wear contact lenses. Symptoms of the infection can be very similar to those of other more common eye infections include eye pain or redness, blurred vision, light sensitivity, the sensation of something in the ye or excessive tearing, but Acanthamoeba is more difficult to treat. Individuals who wear soft contact lenses should stop using the Advanced Medical Optics Complete MoisturePlus product immediately, discard all remaining solution including partially used or unopened bottles, and ask their healthcare professional about choosing an appropriate alternative cleaning/disinfecting product. Individuals should seek immediate treatment if they have symptoms of an eye infection as early diagnosis is important for effective treatment.

Read the complete 2007 Safety summary, including a link to the FDA and Manufacturer's News Releases